[{"id":"6f412c81-9eb0-48e7-8b40-e0e8b91d12d8","acronym":"","url":"https://clinicaltrials.gov/study/NCT05582590","created_at":"2022-10-17T13:56:01.481Z","updated_at":"2024-07-02T16:35:23.356Z","phase":"Phase 1","brief_title":"Autologous T Cells Targeting HPV16 HPV18 \u0026 Survivin in Patients With R/R HPV-related Oropharyngeal Cancers","source_id_and_acronym":"NCT05582590","lead_sponsor":"NexImmune Inc.","biomarkers":" HLA-A","pipe":"","alterations":" ","tags":["HLA-A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • NEXI-003"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 03/31/2025","start_date":" 03/31/2025","primary_txt":" Primary completion: 07/01/2026","primary_completion_date":" 07/01/2026","study_txt":" Completion: 08/25/2027","study_completion_date":" 08/25/2027","last_update_posted":"2024-01-15"}]